Can a smart patch help teens tame type 2 diabetes?

NCT ID NCT06089070

Ongoing Knowledge-focused Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether teenagers with type 2 diabetes will wear and use a continuous glucose monitor (CGM) — a small sensor that tracks blood sugar levels. Twenty participants will use the FreeStyle Libre CGM for 6 months, while 10 others serve as a comparison group. The main goal is to see if the device is acceptable and helpful for managing their diabetes day-to-day.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: FreeStyle Libre continuous glucose monitor (CGM) device
What this could lead to: If successful, this could show that CGM devices are practical and helpful for managing type 2 diabetes in teenagers.
What could go wrong: This is a small, early feasibility study with only 20 participants, so results may not apply to everyone. It focuses on whether teens will use the device, not on proving it improves health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES

Contacts and locations

Locations

University of California San Francisco (UCSF)

San Francisco, California, 94158, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.